Følg
Andreas Scherer
Andreas Scherer
CEO, Spheromics
Verifisert e-postadresse på spheromics.com
Tittel
Sitert av
Sitert av
År
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Nature biotechnology 28 (8), 827-838, 2010
8492010
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
Nature biotechnology 32 (9), 903-914, 2014
8422014
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
C Wang, B Gong, PR Bushel, J Thierry-Mieg, D Thierry-Mieg, J Xu, ...
Nature biotechnology 32 (9), 926-932, 2014
5172014
A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data
J Luo, M Schumacher, A Scherer, D Sanoudou, D Megherbi, T Davison, ...
The pharmacogenomics journal 10 (4), 278-291, 2010
3522010
Reporting guidelines for human microbiome research: the STORMS checklist
C Mirzayi, A Renson, Genomic Standards Consortium, ...
Nature medicine 27 (11), 1885-1892, 2021
1952021
Batch effects and noise in microarray experiments: sources and solutions
A Scherer
Wiley, 2009
1882009
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
IW Deveson, B Gong, K Lai, JS LoCoco, TA Richmond, J Schageman, ...
Nature biotechnology 39 (9), 1115-1128, 2021
1482021
Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies
A Scherer, A Krause, JR Walker, A Korn, D Niese, F Raulf
Transplantation 75 (8), 1323-1330, 2003
1372003
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
Z Tanoli, U Seemab, A Scherer, K Wennerberg, J Tang, M Vähä-Koskela
Briefings in bioinformatics 22 (2), 1656-1678, 2021
952021
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
W Xiao, L Ren, Z Chen, LT Fang, Y Zhao, J Lack, M Guan, B Zhu, ...
Nature biotechnology 39 (9), 1141-1150, 2021
772021
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
JM Jensen, A Scherer, C Wanke, M Bräutigam, S Bongiovanni, M Letzkus, ...
Allergy 67 (3), 413-423, 2012
742012
Predictive biomarkers for chronic allograft nephropathy
A Scherer
US Patent App. 12/295,298, 2010
742010
Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes
S Rödder, A Scherer, F Raulf, CC Berthier, A Hertig, L Couzi, A Durrbach, ...
American journal of transplantation 9 (3), 517-526, 2009
732009
Calmodulin differentially modulates Smad1 and Smad2 signaling
A Scherer, JM Graff
Journal of Biological Chemistry 275 (52), 41430-41438, 2000
692000
Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and …
O Eikrem, C Beisland, K Hjelle, A Flatberg, A Scherer, L Landolt, ...
PloS one 11 (2), e0149743, 2016
652016
Bridging the translational innovation gap through good biomarker practice
AJ van Gool, F Bietrix, E Caldenhoven, K Zatloukal, A Scherer, JE Litton, ...
Nature Reviews Drug Discovery 16 (9), 587-588, 2017
622017
Optimized protocol for linear RNA amplification and application to gene expression profiling of human renal biopsies
A Scherer, A Krause, JR Walker, SE Sutton, D Seron, F Raulf, MP Cooke
Biotechniques 34 (3), 546-556, 2003
582003
Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months
A Scherer, W Gwinner, M Mengel, T Kirsch, F Raulf, JD Szustakowski, ...
Nephrology Dialysis Transplantation 24 (8), 2567-2575, 2009
522009
MDQC: a new quality assessment method for microarrays based on quality control reports
GV Cohen Freue, Z Hollander, E Shen, RH Zamar, R Balshaw, A Scherer, ...
Bioinformatics 23 (23), 3162-3169, 2007
512007
The MAQC-II Project: A comprehensive study of common practices for the development and validation of microarray-based predictive models.
L Shi, G Campbell, W Jones, F Campagne, Z Wen, S Walker, Z Su, T Chu, ...
Nature biotechnology 28 (8), 827-838, 2010
482010
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20